share_log

和黃醫藥：2024年5月10日舉行之股東週年大會–投票表決結果

HUTCHMED: Annual General Meeting held on May 10, 2024 - Poll Results

HKEX ·  May 10, 2024 20:02

Summary by Moomoo AI

和黃醫藥（中國）有限公司於2024年5月10日召開的股東週年大會上，所有提出的普通決議案及特別決議案均獲得通過。其中包括了接納截至2023年12月31日止年度的經審核財務報表、董事會報告及獨立核數師報告，以及重選包括杜志強先生、蘇慰國博士等在內的多位董事。此外，會議還通過了續聘羅兵咸永道會計師事務所及普華永道中天會計師事務所為公司核數師的決議，並授予董事一般性授權以發行及購回公司股份。股東週年大會的投票表決由Computershare Investor Services (Jersey) Limited監票。和黃醫藥是一家專注於癌症和免疫性疾病治療藥物的生物醫藥公司，旗下有三款藥物在中國上市，其中一款亦在美國上市。
和黃醫藥（中國）有限公司於2024年5月10日召開的股東週年大會上，所有提出的普通決議案及特別決議案均獲得通過。其中包括了接納截至2023年12月31日止年度的經審核財務報表、董事會報告及獨立核數師報告，以及重選包括杜志強先生、蘇慰國博士等在內的多位董事。此外，會議還通過了續聘羅兵咸永道會計師事務所及普華永道中天會計師事務所為公司核數師的決議，並授予董事一般性授權以發行及購回公司股份。股東週年大會的投票表決由Computershare Investor Services (Jersey) Limited監票。和黃醫藥是一家專注於癌症和免疫性疾病治療藥物的生物醫藥公司，旗下有三款藥物在中國上市，其中一款亦在美國上市。
At the Annual General Meeting held on 10 May 2024, all proposed Ordinary and Special Resolutions were approved at the Annual General Meeting held on 10 May 2024. This includes the acceptance of audited financial statements for the year ended 31 December 2023, Board reports and independent auditor reports, and the re-election of several directors including Mr. Tu Chi Keung, Dr. Su Lui Kwok. In addition, the meeting adopted a resolution to renew the Company as auditors of the Board of Accountants of Hong Kong and Pwai Yong Road Central Accounting Office and granted the directors general authority to issue and repurchase the Company's shares. Votes at the Annual General Meeting are monitored by Computershare Investor Services (Jersey) Limited. Wah Wong Pharmaceuticals is a biopharmaceutical company focused on medicines for the treatment of cancer and immune diseases. Three drugs are listed in China, including one in the United States.
At the Annual General Meeting held on 10 May 2024, all proposed Ordinary and Special Resolutions were approved at the Annual General Meeting held on 10 May 2024. This includes the acceptance of audited financial statements for the year ended 31 December 2023, Board reports and independent auditor reports, and the re-election of several directors including Mr. Tu Chi Keung, Dr. Su Lui Kwok. In addition, the meeting adopted a resolution to renew the Company as auditors of the Board of Accountants of Hong Kong and Pwai Yong Road Central Accounting Office and granted the directors general authority to issue and repurchase the Company's shares. Votes at the Annual General Meeting are monitored by Computershare Investor Services (Jersey) Limited. Wah Wong Pharmaceuticals is a biopharmaceutical company focused on medicines for the treatment of cancer and immune diseases. Three drugs are listed in China, including one in the United States.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Related Stocks Related Stocks
    Symbol Mini Chart Price
    ANTENGENE-B
    06996
    -- 3.290
    C HEALTH GP
    08225
    -- 0.179
    SINO BIOPHARM
    01177
    -- 3.560
    3SBIO
    01530
    -- 8.520
    HANSOH PHARMA
    03692
    -- 18.800
    Log In for the Full List
    Reassessing Chinese Assets
    Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
    Discussing
    As China's 'two sessions' commence: How will Chinese stocks perform?
    🎙️Discussion 1. With the government's emphasis on technological innovation and sustainability, which industry sectors do you believe hold t Show More
    China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings